AbCellera Biologics Inc.
ABCL
Rankning i aktier
#4041
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Aktiekurs
$12.29
Senast synkroniserad: 2026-10-21
Marknadsvärde
$3.98B
Förändring (1 dag)
4.95%
Förändring (1 år)
124.68%
Land
CA
Handel AbCellera Biologics Inc. (ABCL)
Kategori
Healthcare
Aktiekurshistorik för AbCellera Biologics Inc. (ABCL)
Högsta slutkurs: $12.67 den 2026-10-01
Lägsta slutkurs: $45.73 den 2020-12-01
Lägsta slutkurs: $45.73 den 2020-12-01
Aktiekurshistorik för AbCellera Biologics Inc. från 2020 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 69.44% |
| 2025 | 23.13% |
| 2024 | -44.83% |
| 2023 | -50.84% |
| 2022 | -25.40% |
| 2021 | -68.67% |
| 2020 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.70 | 7.84% |
CH
|
